Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCCAP.L Regulatory News (CCAP)

  • There is currently no data for CCAP

Interim Management Statement

15 Jul 2014 07:00

RNS Number : 2705M
Charlemagne Capital Limited
15 July 2014
 

15 July 2014

 

 

Interim Management Statement for the Six Months Ended 30 June 2014

 

Charlemagne Capital Limited (the "Group") sets out below the key revenue items and assets under management ("AuM") for the first six months of its current financial year. It is expected that the interim financial results will be announced on 16 September 2014.

 

Key highlights and Group AuM

 

§ As at 30 June 2014, Group AuM were US$2.8 billion, up by 3.6% since 1 January 2014;

 

§ Net management fees of US$12.4 million, up 3.3% on the previous six months;

 

· The Group remains well-capitalised with a strong and liquid balance sheet; and

 

· Positive net inflows over the period

 

 

The table below sets out the Group's AuM as at 30 June 2014 and the movements experienced in each product range in the period since 1 January 2014.

 

01-Jan-14

Net Subscriptions

Net Performance

30-Jun-14

Movement In

AuM (US$m)

(US$m)

(%)

(US$m)

(%)

AuM (US$m)

Period (%)

Magna

560

124

22.1

37

5.9

721

28.8

OCCO

664

23

3.5

0

0.0

687

3.5

Institutional

1,373

(111)

(8.1)

16

1.2

1,278

(6.9)

Specialist

134

12

9.0

(3)

(2.1)

143

6.7

Total

2,731

48

1.8

50

1.8

2,829

3.6

 

Notes:

Closing AuM is stated as including all subscription and redemption orders received for the relevant funds as at the close of the period but not processed until the first dealing date of the following period.

 

Unaudited revenue numbers for the six months ended 30 June 2014

 

Net management fees receivable were US$12.4 million compared with US$12.0 million for the previous six months and US$11.9 million for the comparable period of 2013, reflecting the small increase in average AuM and net margin arising over the period. OCCO management fees, which are subject to a minority interest, accounted for over 45% of total net management fee income during the period.

 

Crystallised performance fees were US$0.3 million compared with US$0.5 million for the comparative period in 2013. Accruing performance fees1 for 2014 which have not crystallised were US$0.5 million compared with US$5.9 million as at the same date in 2013.

 

_________________________________________________________________________

1Performance fees accrue throughout the reporting period in the accounts of each relevant fund. It is the group's accounting policy only to recognise such revenues as they crystallise at the year-end date of the fund or, in certain cases, on redemption. Levels of accrued performance fees at any particular time should not be seen as necessarily indicative of the eventual crystallised figures, especially in periods of above average market volatility.

 

Dividend

 

In the absence of unforeseen circumstances, the Group intends to declare an interim dividend in respect of the six months to 30 June 2014. Further details will be provided in the interim results announcement planned for 16 September 2014.

 

Summary

 

Emerging markets have returned a positive performance over the six month period with gains in the second quarter overcoming negative returns in the first, the low point being in February. The MSCI Emerging markets index was up by 6.6% for the quarter resulting in a 6.1% (in US$) gain over the full half year. This turnaround follows six months of heavy and almost continuous selling by mutual funds and suggests that sentiment may be turning. Investors are adjusting to the ending of super-easy monetary policy in the US, with emerging currencies recovering from weakness of the previous nine months, while political risk has reduced following the BJP' victory in India as well as elections in South Africa, Turkey and Indonesia.

 

Over the period, four of the nine Magna sub-funds were in the top half of their FactSet Morningstar peer group. The overall performance in the institutional funds business was lower than the broader market performance, because a number of the largest mandates are focused on Eastern Europe or Russia. These were the markets most affected by the crisis in Ukraine, which showed signs of abating towards the end of the half.

 

The positive net inflows into the Magna funds over the first half of the year are predominantly due to subscriptions into the Magna Emerging Markets Dividend Fund with net inflows also achieved into MENA and Frontier funds. The institutional business was impacted by rebalancing of existing mandates, together with outflows from sub advisory business. The OCCO Eastern European Fund had net inflows as capacity from earlier redemptions was filled.

 

Outlook

 

During the year to date, emerging markets have performed similarly to developed markets after a sustained period of underperformance. The industry has reported outflows from dedicated emerging markets funds over the period although this trend has started to reverse in the most recent quarter. While economic growth in some countries may be subdued, the outlook for many is improving. From a bottom up perspective, we see evidence of more realistic earnings expectations, which should help share prices in the asset class.

 

The Group has again seen net inflows in a challenging environment and has achieved modest growth in AuM. The current level of AuM remains below that required to ensure sustainable profits on a recurring management fee basis and the generation of performance fees during the remainder of the year will be a significant factor in determining full year profit levels.

 

Enquiries:

 

Charlemagne Capital

 

Jayne Sutcliffe, Chief Executive

Tel. 020 7518 2100

Lloyd Jones, Finance Director

Tel. 01624 640200

 

 

N+1 Singer

Tel. 020 7496 3000

Jonny Franklin-Adams

Nick Donovan

 

 

 

Smithfield Consultants

Tel. 020 7360 4900

John Kiely

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSDMGMNDDVGDZM
Date   Source Headline
20th Jan 20219:05 amRNSSecond Price Monitoring Extn
20th Jan 20219:00 amRNSPrice Monitoring Extension
18th Jan 202110:00 amRNSIssue of Equity and Total Voting Rights
12th Jan 20218:22 amRNSTR-1: Notification of major holdings
11th Jan 20214:35 pmRNSPrice Monitoring Extension
11th Jan 202111:31 amRNSIssue of Equity and Total Voting Rights
11th Jan 20219:00 amRNSTR-1: Notification of major holdings
11th Jan 20217:00 amRNSTR-1: Notification of major holdings
7th Jan 20219:05 amRNSSecond Price Monitoring Extn
7th Jan 20219:00 amRNSPrice Monitoring Extension
6th Jan 20215:32 pmRNSTR-1: Notification of major holdings
2nd Dec 20202:06 pmRNSSecond Price Monitoring Extn
2nd Dec 20202:00 pmRNSPrice Monitoring Extension
20th Nov 20209:05 amRNSSecond Price Monitoring Extn
20th Nov 20209:00 amRNSPrice Monitoring Extension
18th Nov 20207:00 amRNSTR-1: Notification of major holdings
19th Oct 20202:41 pmRNSWarrant Update
7th Oct 20202:05 pmRNSSecond Price Monitoring Extn
7th Oct 20202:00 pmRNSPrice Monitoring Extension
6th Oct 20203:08 pmRNSNew Website
14th Dec 20164:01 pmRNSScheme Effective
13th Dec 20164:15 pmRNSCourt Sanction of Scheme
13th Dec 20167:30 amRNSSuspension - Charlemagne Capital Limited
12th Dec 20168:05 amRNSDocument re: Charlemagne Capital
12th Dec 20168:01 amRNSSuspension of Dealings and Transfers
9th Dec 201610:55 amRNSDocument re: Charlemagne Capital
8th Dec 20161:22 pmRNSConfirmation of Regulatory Clearance
8th Dec 201611:36 amRNSDocument re: Charlemagne Capital
7th Dec 20164:25 pmRNSDocument re: Charlemagne Capital
7th Dec 20164:21 pmRNSDocument re: Charlemagne Capital
2nd Dec 20165:19 pmRNSResults of the Court Meeting
10th Nov 20167:00 amRNSScheme Circular
14th Oct 20163:05 pmRNSDocument re: Charlemagne Capital
12th Oct 20167:00 amRNSQ3 2016 AUM Update
3rd Oct 20163:30 pmRNSTR-1: Notification of Major Interest in Shares
30th Sep 20163:01 pmRNSOPD - Charlemagne Capital - Replacement
30th Sep 20162:50 pmRNSDoc re. Charlemagne Capital
30th Sep 20167:00 amRNSForm 8 (OPD) Charlemagne Capital plc
30th Sep 20167:00 amRNSRecommended Cash Offer for Charlemagne
30th Sep 20167:00 amRNSHalf Yearly Report
19th Sep 201611:01 amRNSTR-1: Notification of Major Interest in Shares
14th Jul 20167:00 amRNSTrading Statement
27th Jun 20164:40 pmRNSSecond Price Monitoring Extn
27th Jun 20164:35 pmRNSPrice Monitoring Extension
17th Jun 20161:56 pmRNSResult of AGM
20th May 20164:38 pmRNSAnnual Report and Notice of AGM
28th Apr 20161:22 pmRNSTR-1: Notification of Major Interest in Shares
15th Apr 201610:08 amRNSTR-1: Notification of Major Interest in Shares
11th Apr 20167:00 amRNSQ1 2016 AUM Update
24th Mar 20169:16 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.